NHC Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, 1163 Xinmin Street, Changchun, 130021, People's Republic of China.
J Cancer Res Clin Oncol. 2018 Dec;144(12):2303-2311. doi: 10.1007/s00432-018-2731-4. Epub 2018 Aug 16.
Autophagy, as a highly conserved cellular degradation and recycling process, plays an important part in maintaining cellular homeostasis. PKC signaling is involved in multiple pathways including cell cycle progression, tumorigenesis, migration and autophagy.
Literatures about PKC and autophagy from PubMed databases were reviewed in this study.
Studies regarding the association of PKC and autophagy remain debatable. Different duration of the stimulation of autophagy and distinct cell contexts result in different function of PKC in regulating autophagy. The subcellular localization of PKCs and their downstream regulators may influence the autophagy regulation as well. As important intracellular components, the mitochondria play an important role in regulating autophagy, by metabolic modulation and structural derangement.
Phase II studies regarding PKC-β inhibitor, enzastaurin, showed promising results in MCL, DLBCL and recurrent high-grade gliomas. However, the detailed mechanism is still in need. The mechanism of PKC-β in mediating autophagy in lymphoma and high-grade gliomas remains elusive as well. Moreover, several studies were in agreement that rottlerin enhanced autophagy in breast cancer cells, which warrants further clinical studies to verify PKC-δ as a therapeutic target. Thus, identifying the function of PKC in modulating autophagy and conducting related clinical studies help find novel target for chemotherapy.
自噬作为一种高度保守的细胞降解和回收过程,在维持细胞内稳态中起着重要作用。蛋白激酶 C(PKC)信号转导参与包括细胞周期进展、肿瘤发生、迁移和自噬在内的多种途径。
本研究通过查阅 PubMed 数据库中有关 PKC 和自噬的文献进行综述。
关于 PKC 和自噬之间关联的研究仍存在争议。自噬刺激的持续时间不同,细胞环境也不同,导致 PKC 在调节自噬方面的功能也不同。PKC 及其下游调节因子的亚细胞定位也可能影响自噬的调节。作为重要的细胞内成分,线粒体通过代谢调节和结构紊乱在调节自噬中发挥重要作用。
关于 PKC-β 抑制剂恩杂鲁胺的 II 期研究在套细胞淋巴瘤、弥漫性大 B 细胞淋巴瘤和复发性高级别神经胶质瘤中显示出有前景的结果。然而,其详细的机制仍需要进一步研究。PKC-β 在淋巴瘤和高级别神经胶质瘤中介导自噬的机制也尚不清楚。此外,一些研究一致表明,rottlerin 增强了乳腺癌细胞的自噬,这需要进一步的临床研究来验证 PKC-δ 作为治疗靶点。因此,确定 PKC 在调节自噬中的作用并进行相关的临床研究有助于为化疗寻找新的靶点。